Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome.

NCT03059160 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER_GOV

Sponsor class

Conditions

Rett Syndrome

Interventions

DRUG: Tridecanoic Acid

Sponsor

Sheba Medical Center

Collaborators

[object Object]